King Wealth Management Group

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1568235 SARATOGA SPRINGS, NY

Position in HRTX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$14,103

-$12,136 QoQ

Shares Held

32,799

0.0% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#87

of 161 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

King Wealth Management Group holds $1,215,114 across 5 Biotechnology names. HRTX ranks #5 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PTGX	Protagonist Therapeutics, Inc	4,000	$490,320
2	DFTX	Definium Therapeutics, Inc.	10,000	$470,400
3	INSM	INSMED Inc	2,000	$213,240
4	ALDX	Aldeyra Therapeutics, Inc.	12,700	$27,051
5	HRTX	Heron Therapeutics, Inc. /De/ This page	32,799	$14,103

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,103	32,799	0.0%	Shares	Sole	2026-08-05
2026-03-31	$26,239	32,799	+6.5%	Shares	Sole	2026-05-04
2025-12-31	$40,038	30,799	+3.4%	Shares	Sole	2026-02-09
2025-09-30	$37,546	29,799	+3.5%	Shares	Sole	2025-11-07
2025-06-30	$59,613	28,799	+7.5%	Shares	Sole	2025-08-08
2025-03-31	$58,957	26,799	0.0%	Shares	Sole	2025-05-08
2024-12-31	$41,002	26,799	+15.0%	Shares	Sole	2025-02-10
2024-09-30	$46,365	23,299	+52.3%	Shares	Sole	2024-11-06
2024-06-30	$53,546	15,299	+51.5%	Shares	Sole	2024-08-08
2024-03-31	$27,974	10,099	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.